Clinical Trials Browser

Phase 1/2 × Carcinoma, Ovarian Epithelial × paclitaxel poliglumex × Clear all

NCT00017017 2013-05-30

CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer

Phase 1/2 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms